Stay updated on Tirzepatide in HFpEF & Obesity Clinical Trial

Sign up to get notified when there's something new on the Tirzepatide in HFpEF & Obesity Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tirzepatide in HFpEF & Obesity Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update or modification in the study details related to the efficacy and safety assessment of Tirzepatide in participants with heart failure and obesity.
    Difference
    0.1%
    Check dated 2024-06-06T14:26:42.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    9 days ago
    Change Detected
    Summary
    The value (Estimated) has recently changed to . This change likely indicates an update or revision in the estimated completion date for the study related to Tirzepatide in participants with heart failure with preserved ejection fraction and obesity.
    Difference
    0.0%
    Check dated 2024-05-31T10:29:41.000Z thumbnail image
  7. Check
    10 days ago
    Change Detected
    Summary
    The recent change on the webpage now includes new locations in Campinas, São Paulo, Brazil, Lanzhou, Gansu, China, Ponce, Puerto Rico, and Taipei, Taiwan, along with updated estimated dates. These additions likely indicate the expansion of the study to include research sites in these regions for medical and healthcare-related publications and documentation.
    Difference
    2%
    Check dated 2024-05-30T09:33:42.000Z thumbnail image
  8. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying conditions such as stable heart failure, elevated NT-proBNP levels, and other health parameters. This change provides more specific information about the health conditions and prior treatments required for study participation.
    Difference
    9%
    Check dated 2024-05-22T21:32:51.000Z thumbnail image
  9. Check
    39 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-04-30T22:59:56.000Z thumbnail image

Stay in the know with updates to Tirzepatide in HFpEF & Obesity Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tirzepatide in HFpEF & Obesity Clinical Trial page.